Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | 2 | HGF | 21.0 | 43 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 56.0 | 53 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 46.5 | 72 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 28.0 | 58 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 24.0 | 71 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 21.5 | 54 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 24.0 | 52 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 52.0 | 43 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | HGF | 44.0 | 59 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 23.5 | 42 | |
N2645 | TNF-a | 100 | ng/mL | 2 | HGF | 19.5 | 34 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | HGF | 25.0 | 43 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | HGF | 21.5 | 38 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 68.0 | 56 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 59.0 | 57 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 44.5 | 42 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 39.0 | 35 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 40.0 | 47 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 34.5 | 26 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 85.0 | 45 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | HGF | 65.0 | 37 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 41.0 | 45 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | HGF | 36.0 | 37 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | HGF | 40.0 | 50 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | HGF | 37.0 | 48 |